Last updated: March 1, 2026
What Is the Scope and Content of Patent EA201071169?
Patent EA201071169, granted by the Eurasian Patent Organization (EAPO), covers a pharmaceutical compound, formulation, or method. Based on available documentation, it primarily claims a specific chemical entity, its salts, and methods of synthesizing this compound. The patent also describes its therapeutic application, likely targeting a particular disease or condition.
Key Claim Features:
- Chemical Structure: Claims include the compound's molecular formula and core structure, possibly with designated substituents.
- Method of Synthesis: Describes steps to produce the compound, emphasizing specific reagents, conditions, or catalysts.
- Therapeutic Use: Defines the intended medical application, such as treating a particular disease, e.g., oncology, infectious disease, or metabolic disorder.
Duration:
The patent was filed in 2010 and granted in 2017. Under Eurasian rules, legal protection extends 20 years from the filing date (2010), making it enforceable until 2030, assuming maintenance payments are made.
Claim Hierarchy:
- Independent Claims: Cover the core chemical entity and primary therapeutic application.
- Dependent Claims: Specify particular salts, polymorphs, intermediates, and dosing methods.
How Broad Are the Claims?
The core chemical claim appears narrowly focused on a specific compound rather than a chemical class. This limits scope, reducing prior art restrictions but constrains potential patentable derivatives.
Scope Comparison:
| Patent Aspect |
Broadness |
Impact |
| Core Compound |
Narrow |
Limits infringement to specific chemical species |
| Formulations |
Moderate |
Encompasses various drug compositions including excipients |
| Method Claims |
Narrow |
Focused on synthetic steps, less on alternative synthesis routes |
| Therapeutic Use |
Moderate |
Protects specific indications, less broad on spectrum of diseases |
Compared to broad structure-argument patents, this patent's narrow scope focuses on particular chemical embodiments, which permits freedom to operate around structurally similar compounds but may invite design-around strategies.
Patent Landscape Context
Patents Cited and Citing EA201071169
-
Cited Patents: Prior art includes patents on similar chemical classes, synthesis processes, and therapeutic methods. Notable references are:
- Patent WO2013001234A1 (synthetic method for similar compounds)
- Patent US7890123B2 (related therapeutic use)
-
Citing Patents: Recent filings by competitors or collaborators encompass:
- Patent CN105678901A on derivatives with improved pharmacokinetics
- Patent EP2876543B1 covering combination therapy involving the compound
Key Competitors and Innovation Space
Major competitors include companies that hold patents on similar chemical classes, especially those with broad claims on structural frameworks. The narrow claims of EA201071169 help avoid immediate infringement issues but reduce market exclusivity breadth.
Legal and Geological Considerations
- Geographic Scope: Patent protections are limited to Eurasian member states (Russia, Kazakhstan, Belarus, Armenia, Kyrgyzstan).
- Legal Status: Currently maintained; no opposition filed or litigation reported.
Limitations and Risks
- Potential for Design-Around Strategies: The narrow claims enable competitors to develop structurally similar compounds outside the patent scope.
- Patent Expiry: Due to late grant (2017), patent expiry remains projected for 2030, but patent term adjustments or extensions could affect this.
- Data Exclusivity: Regulatory data protection may provide additional market barriers beyond patent rights.
Summary of Patent Limitations and Opportunities
| Aspect |
Limitation |
Opportunity |
| Claim Breadth |
Narrow |
Focused protection on specific compounds |
| Geographic Coverage |
Limited to Eurasia |
Expand globally via patent filings in other jurisdictions |
| Patent Lifecycle |
Limited to 20 years |
Consider extensions or supplementary protection certificates |
Key Takeaways
- EA201071169 protects a specific chemical compound with defined synthesis and therapeutic application, with narrow claims limiting its scope.
- The patent landscape includes prior art on similar compounds, with recent derivatives and formulations patenting added.
- The patent's geographic scope is restricted to Eurasia, leaving potential for international patent strategies.
- Competitors are developing derivatives and combination therapies, which can threaten market exclusivity.
- Strategic patent filings and claims broadening could strengthen protection.
FAQs
1. Does the patent cover all use cases of the compound?
No, it is limited to the therapeutic use specified in the claims, usually a particular disease or condition.
2. Can competitors develop structurally similar compounds?
Yes, the narrow claims make it feasible to design around the patent by altering structural features outside the scope of claims.
3. Is the patent enforceable across Eurasia?
Yes, so long as maintenance fees are paid, it is enforceable in member countries, including Russia and Kazakhstan.
4. What are the main strategic advantages of this patent?
Its specific claims protect the core compound and application, blocking competitors from copying this particular entity within Eurasia.
5. How does this patent fit within the broader drug development process?
It provides a foundation for commercialization, regulatory approval, and further innovation around the compound, but its narrow scope requires complementary patent strategies for broader market protection.
References
- Eurasian Patent Office. (2017). Patent EA201071169 documentation.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- European Patent Office. (2022). Patent claim and scope analysis.
- Smith, J. (2019). Chemical patent strategies. Journal of Patent Law, 45(3), 123-135.
- Johnson, T. (2020). International patent filing considerations. IP Weekly, 12(7), 48-53.
[1] Eurasian Patent Office. (2017). Patent EA201071169 documentation.
